middle.news
Imagion Biosystems Advances Phase 1b/2 Trial with CRO Agreements and Product Ready
9:47am on Wednesday 26th of August, 2026 AEST
•
Healthcare
Read Story
Imagion Biosystems Advances Phase 1b/2 Trial with CRO Agreements and Product Ready
9:47am on Wednesday 26th of August, 2026 AEST
Key Points
Work orders signed with primary and specialist CROs
MagSense investigational product manufacturing complete
Seven prospective trial sites engaged with first US site contracting
Imaging protocol includes advanced MRI techniques
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imagion Biosystems (ASX:IBX)
OPEN ARTICLE